Ryotaro Kuroda

555 total citations
17 papers, 462 citations indexed

About

Ryotaro Kuroda is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Surgery. According to data from OpenAlex, Ryotaro Kuroda has authored 17 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Ryotaro Kuroda's work include Brain Metastases and Treatment (5 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Treatment and Pharmacology (3 papers). Ryotaro Kuroda is often cited by papers focused on Brain Metastases and Treatment (5 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Treatment and Pharmacology (3 papers). Ryotaro Kuroda collaborates with scholars based in Japan. Ryotaro Kuroda's co-authors include Mamoru Taneda, Akira Kinoshita, Toshiharu Asai, Mamoru Ito, Kazuo Kataoka, Atsufumi Kawabata, Hiroyuki Nishikawa, Hiromasa Araki, Kenzo Kawai and Tõru Hayakawa and has published in prestigious journals such as Stroke, British Journal of Cancer and Life Sciences.

In The Last Decade

Ryotaro Kuroda

16 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryotaro Kuroda Japan 6 336 158 93 62 49 17 462
Ram Narayan United States 11 233 0.7× 65 0.4× 86 0.9× 60 1.0× 25 0.5× 35 447
Susanne Gaertner Germany 7 147 0.4× 114 0.7× 92 1.0× 44 0.7× 25 0.5× 9 388
C Vital France 13 194 0.6× 53 0.3× 75 0.8× 122 2.0× 49 1.0× 61 502
Kazuya Kanemaru Japan 13 355 1.1× 145 0.9× 44 0.5× 35 0.6× 43 0.9× 44 490
N Miyazawa Japan 14 116 0.3× 149 0.9× 80 0.9× 73 1.2× 25 0.5× 29 501
P. van Breda Vriesman Netherlands 10 106 0.3× 129 0.8× 55 0.6× 58 0.9× 11 0.2× 19 354
Michael von Gunten Switzerland 14 229 0.7× 122 0.8× 52 0.6× 43 0.7× 26 0.5× 29 381
Judith A. Fryer Australia 7 82 0.2× 118 0.7× 27 0.3× 45 0.7× 13 0.3× 17 330
David S. Younger United States 14 605 1.8× 43 0.3× 20 0.2× 89 1.4× 29 0.6× 33 731
Hayato Yamazaki Japan 10 311 0.9× 52 0.3× 211 2.3× 47 0.8× 47 1.0× 14 602

Countries citing papers authored by Ryotaro Kuroda

Since Specialization
Citations

This map shows the geographic impact of Ryotaro Kuroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryotaro Kuroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryotaro Kuroda more than expected).

Fields of papers citing papers by Ryotaro Kuroda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryotaro Kuroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryotaro Kuroda. The network helps show where Ryotaro Kuroda may publish in the future.

Co-authorship network of co-authors of Ryotaro Kuroda

This figure shows the co-authorship network connecting the top 25 collaborators of Ryotaro Kuroda. A scholar is included among the top collaborators of Ryotaro Kuroda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryotaro Kuroda. Ryotaro Kuroda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kawabata, Atsufumi & Ryotaro Kuroda. (2002). [PAR (protease-activated receptor) as a novel target for development of gastric mucosal cytoprotective drugs].. PubMed. 120(1). 85P–87P. 1 indexed citations
2.
Kawabata, Atsufumi, et al.. (2000). Characterization of the protease-activated receptor-1-mediated contraction and relaxation in the rat duodenal smooth muscle. Life Sciences. 67(20). 2521–2530. 31 indexed citations
3.
Kataoka, Kazuo, Mamoru Taneda, Toshiharu Asai, et al.. (1999). Structural Fragility and Inflammatory Response of Ruptured Cerebral Aneurysms. Stroke. 30(7). 1396–1401. 369 indexed citations
4.
Kawabata, Atsufumi, Taeko Hata, & Ryotaro Kuroda. (1998). Cross tolerance to environmental stress and endotoxin. Life Sciences. 62(21). PL327–PL333. 5 indexed citations
5.
Takemura, Motohide, et al.. (1998). Effects of SI and SII electrical stimulation of formalin induced c-Fos expression in the trigeminal nucleus caudalis in the rat. Neuroscience Research. 31. S198–S198. 2 indexed citations
6.
Kataoka, Kazuo, et al.. (1995). Clipping Techniques for the Juxta-Dural Ring Aneurysms. Surgery for Cerebral Stroke. 23(1). 55–60. 1 indexed citations
7.
Kuroda, Ryotaro, et al.. (1994). Interstitial Chemotherapy with Biodegradable ACNU Pellet for Glioblastoma. Stereotactic and Functional Neurosurgery. 63(1-4). 154–159. 9 indexed citations
8.
Honjo, Tomoko, et al.. (1993). [Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].. PubMed. 20(14). 2201–5. 4 indexed citations
9.
Honjo, Tomoko, et al.. (1993). [Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis].. PubMed. 20(15). 2369–73. 11 indexed citations
10.
Izumoto, Shuichi, Norio Arita, Y Ushio, et al.. (1988). [Growth activity of meningeal carcinomatosis--immunohistochemical study using anti-BrdU monoclonal antibody].. PubMed. 40(2). 127–31. 2 indexed citations
11.
Watanabe, Misa, et al.. (1977). [Clinical study on penetration of antibiotics into cerebrospinal fluid (second report),-Study on intravenous administration of sodium cephalothin with mannitol solution (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(2). 137–43. 1 indexed citations
12.
Hayakawa, Tõru, et al.. (1975). Argon laser treatment of brain tumor sensitized with acridine orange.. PubMed. 26(12). 61–7. 6 indexed citations
13.
Hayakawa, Tõru, et al.. (1970). Intrathecal Chemotherapy. British Journal of Cancer. 24(3). 489–497. 11 indexed citations
14.
Yamada, Ryoji, et al.. (1968). Experimental studies of the chemotherapy of brain tumors. 1. Distribution of cytostatic agents in the serum, cerebrospinal fluid and brain tissue after intravenous, intracarotid and intrathecal administration.. PubMed. 18(4). 373–88. 3 indexed citations
15.
Hayakawa, T, et al.. (1968). Experimental studies on the chemotherapy of brain tumors. 2. Localization of cytostatic agents in central nervous tissue after intravenous, intracarotid and intrathecal administration.. PubMed. 18(4). 389–95. 3 indexed citations
16.
Jinnai, Dennosuke, et al.. (1967). [Chemotherapy of brain tumors, with reference to the selection of carcinostatics for intrathecal administration and the distribution of concentration of carcinostatics in various administrations].. PubMed. 19(4). 333–7. 2 indexed citations
17.
Mogami, H, et al.. (1967). Selection of cytostatic agents for intrathecal chemotherapy of brain tumor.. PubMed. 17(3). 333–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026